T. Takeyuki Kurata

T. Takeyuki Kurata's AcademicInfluence.com Rankings

T. Takeyuki Kurata

Biology

#12910

World Rank

#16416

Historical Rank

Virology

#315

World Rank

#322

Historical Rank

Microbiology

#783

World Rank

#859

Historical Rank

biology Degrees

Download Badge

Biology

T. Takeyuki Kurata's Degrees

PhD Virology Kyoto University
Doctorate Medicine Kyoto University

Why Is T. Takeyuki Kurata Influential?

(Suggest an Edit or Addition)

(See a Problem?)

T. Takeyuki Kurata's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM (1988) (1434)
A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a (1986) (307)
Transgenic mice susceptible to poliovirus. (1991) (297)
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I (2006) (282)
Defense mechanisms against influenza virus infection in the respiratory tract mucosa. (2004) (273)
Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection (2005) (252)
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. (2000) (245)
Protection Against Influenza Virus Infection in Polymeric Ig Receptor Knockout Mice Immunized Intranasally with Adjuvant-Combined Vaccines (2002) (211)
Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. (1988) (206)
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition (2007) (206)
Isolation and characterization of mouse nasal-associated lymphoid tissue. (1997) (203)
Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. (2005) (192)
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. (1992) (168)
Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. (1992) (156)
Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules (1991) (156)
Molecular Investigation of the Aum Shinrikyo Anthrax Release in Kameido, Japan (2001) (149)
Swelling and Shrinking Kinetics of Totally Synthetic, Glucose-Responsive Polymer Gel Bearing Phenylborate Derivative as a Glucose-Sensing Moiety (2004) (138)
Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine (1992) (134)
Microtubule Network Facilitates Nuclear Targeting of Human Cytomegalovirus Capsid (2003) (133)
Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. (1996) (132)
Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine (2007) (132)
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. (1990) (129)
Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virus (2004) (128)
Isolation of Borna Disease Virus from Human Brain Tissue (2000) (127)
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. (1996) (126)
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. (2000) (123)
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. (1998) (115)
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. (1998) (115)
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. (1990) (113)
Facial Nerve Paralysis Induced by Herpes Simplex Virus in Mice: An Animal Model of Acute and Transient Facial Paralysis (1995) (112)
High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. (1999) (108)
Continuous Presence of Noroviruses and Sapoviruses in Raw Sewage Reflects Infections among Inhabitants of Toyama, Japan (2006 to 2008) (2009) (106)
An infectious DNA clone of HIV type 1 subtype C. (1999) (103)
Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. (1996) (103)
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. (2007) (95)
Identification of Antigenic Proteins Encoded by Human Herpesvirus 8 and Seroprevalence in the General Population and among Patients with and without Kaposi's Sarcoma (2000) (95)
Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence (1994) (94)
Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. (2000) (94)
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia. (2003) (93)
Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. (1999) (93)
LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox (2006) (91)
Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus (1990) (90)
Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. (1992) (90)
Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. (2009) (87)
Protective Mucosal Immunity in Aging Is Associated with Functional CD4+ T Cells in Nasopharyngeal-Associated Lymphoreticular Tissue 1 (2003) (87)
Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis (2002) (86)
Bacillus anthracis Bioterrorism Incident, Kameido, Tokyo, 1993 (2004) (86)
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. (1999) (83)
Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice (2003) (81)
Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. (1991) (81)
An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection (2005) (76)
Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. (1995) (75)
Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. (2000) (73)
Laboratory Diagnostic Systems for Ebola and Marburg Hemorrhagic Fevers Developed with Recombinant Proteins (2006) (73)
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. (2005) (73)
Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. (1989) (72)
p180 is involved in the interaction between the endoplasmic reticulum and microtubules through a novel microtubule-binding and bundling domain. (2007) (70)
Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. (2009) (67)
Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. (1995) (67)
Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). (2000) (65)
Isotype-specific Selection of High Affinity Memory B Cells in Nasal-associated Lymphoid Tissue (2001) (65)
Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. (1986) (64)
Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease (1999) (64)
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. (2006) (62)
Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. (1989) (61)
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults (2013) (59)
Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. (1992) (58)
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. (2003) (57)
Pathogenicity of tick-borne encephalitis virus isolated in Hokkaido, Japan in mouse model. (1999) (57)
Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. (1987) (56)
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant (2005) (55)
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. (2001) (55)
Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice. (1987) (54)
Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation (2004) (54)
Evidence of lytic infection of Epstein‐Barr virus (EBV) in EBV‐positive gastric carcinoma (2002) (54)
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. (1989) (53)
Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine (2010) (53)
Lack of susceptibility of various primates and woodchucks to hepatitis C virus. (1993) (52)
Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies. (2001) (51)
Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine. (1999) (51)
Frequent Detection of Noroviruses and Sapoviruses in Swine and High Genetic Diversity of Porcine Sapovirus in Japan during Fiscal Year 2008 (2010) (51)
IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. (1998) (50)
Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS‐associated Kaposi's sarcoma (1999) (49)
Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model. (2007) (49)
Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. (1995) (49)
Amino Acid 36 in the Human Immunodeficiency Virus Type 1 gp41 Ectodomain Controls Fusogenic Activity: Implications for the Molecular Mechanism of Viral Escape from a Fusion Inhibitor (2005) (49)
Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine (2003) (49)
Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficiency virus type 1. (1999) (48)
Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues (1996) (48)
Fatal acute myocarditis in an infant with human herpesvirus 6 infection. (2001) (48)
Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. (2001) (48)
Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. (2005) (47)
Detection of Viral Antigens in Formalin‐fixed Specimens by Enzyme Treatment (1983) (47)
H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. (1991) (46)
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. (1994) (46)
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. (1995) (45)
Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. (2000) (45)
Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus (2010) (43)
Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine. (1998) (43)
The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane. (1991) (41)
Protection against influenza B virus infection by immunization with DNA vaccines. (2001) (41)
Isolation of hemorrhagic fever with renal syndrome (HFRS) virus from a tumor specimen in a rat. (1983) (40)
Persistent infection of rats with haemorrhagic fever with renal syndrome virus and their antibody responses. (1986) (40)
Demonstration of varicella-zoster virus antigens in the vitreous aspirates of patients with acute retinal necrosis syndrome. (1988) (40)
Induction of cross‐protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia (2010) (39)
Hair follicle involvement in herpes zoster: pathway of viral spread from ganglia to skin (1996) (39)
Development of Recombinant Nucleoprotein-Based Diagnostic Systems for Lassa Fever (2007) (39)
Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate. (2010) (39)
Experimental transmission of non-A, non-B hepatitis by saliva. (1987) (39)
Loss of membrane excitability after herpes simplex virus infection in tissue-cultured nerve cells from adult mammals (1981) (38)
An Endoplasmic Reticulum Protein, p180, Is Highly Expressed in Human Cytomegalovirus-Permissive Cells and Interacts with the Tegument Protein Encoded by UL48 (2002) (37)
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses. (2003) (37)
Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains. (2008) (36)
CELLULAR AND HUMORAL IMMUNE RESPONSES IN MICE (1973) (36)
Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. (1998) (36)
Cross‐reactive antigenicity of nucleoproteins of lyssaviruses recognized by a monospecific antirabies virus nucleoprotein antiserum on paraffin sections of formalin‐fixed tissues (2003) (36)
Effect of Transforming Growth Factor-β1 on the Cell Growth and Epstein–Barr Virus Reactivation in EBV-Infected Epithelial Cell Lines (2001) (35)
Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus (1988) (35)
Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment. (1978) (35)
Experimental Infection in Newborn Mice and Rats by Hemorrhagic Fever with Renal Syndrome (HFRS) Virus (1984) (35)
The use of mice in the Sereny test as a virulence assay of shigellae and enteroinvasive Escherichia coli (1986) (35)
Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. (1997) (35)
Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti‐HPV monoclonal antibody (1992) (34)
Interleukin-4 production in Epstein-Barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. (1997) (34)
Pathogenesis of Hantaan virus in mice. (1989) (34)
Nucleolin and the Packaging Signal, ψ, Promote the Budding of Human Immunodeficiency Virus Type‐1 (HIV‐1) (2004) (33)
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine? (2016) (33)
Genetic Characterization of Hantaviruses Transmitted by the Korean Field Mouse (Apodemus peninsulae), Far East Russia (2002) (33)
Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K). (2002) (33)
Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. (2004) (33)
Human herpesvirus-6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients (1995) (33)
Nonsense mutations in the vpr gene of HIV‐1 during in vitro virus passage and in HIV‐1 carrier‐derived peripheral blood mononuclear cells (1994) (33)
Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study. (2003) (32)
Enzymatic treatment of formalin-fixed and paraffin-embedded specimens for detection of antigens of herpes simplex, varicella-zoster and human cytomegaloviruses. (1982) (32)
Presence of a novel hamster oral papillomavirus in dysplastic lesions of hamster lingual mucosa induced by application of dimethylbenzanthracene and excisional wounding: molecular cloning and complete nucleotide sequence. (1997) (32)
Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein‐Barr virus infection (1993) (32)
Pathology of the human spinal ganglia in varicella-zoster virus infection (1975) (32)
High susceptibility of Mongolian gerbil (Meriones unguiculatus) to Borna disease virus. (1999) (32)
Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant (2006) (31)
A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine. (2000) (31)
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies. (2005) (31)
Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. (1992) (31)
Pathologic features of acquired immunodeficiency-like syndrome in cats experimentally infected with feline immunodeficiency virus. (1993) (30)
Presence of antibody to human herpesvirus 6 in monkeys. (1989) (30)
Human Herpesvirus 6 (HHV‐6) Infection in the Central Nervous System (1992) (30)
Cochlear changes after herpes simplex virus infection. (1985) (30)
Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic (2007) (29)
Genetic and phylogenetic analysis of HIV type 1 env subtypes in Ghana, west Africa. (1996) (28)
Characterization of antibodies raised against bovine-PrP-peptides. (1999) (28)
Characterization of Oita virus 296/1972 of Rhabdoviridae isolated from a horseshoe bat bearing characteristics of both lyssavirus and vesiculovirus (2004) (28)
Pretreatment with Restriction Enzyme or Bovine Serum Albumin for Effective PCR Amplification of Epstein-Barr Virus DNA in DNA Extracted from Paraffin-Embedded Gastric Carcinoma Tissue (1998) (28)
Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. (2001) (27)
Enteropathogenic and enterotoxigenic activities on ligated gut loops in rabbits of Salmonella and some other enterobacteria isolated from human patients with diarrhea. (1974) (27)
Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. (1998) (27)
Inhibition of Human Immunodeficiency Virus Type 1 Virion Entry by Dominant-Negative Hck (1998) (26)
Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion. (1991) (25)
Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column. (2011) (25)
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses (2009) (25)
Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments. (2010) (25)
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination. (2000) (25)
Serological and clinical study of herpes simplex virus infection in patients with sudden deafness. (1988) (25)
A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21. (2004) (24)
Immunohistochemical study of skin lesions in herpes zoster (2005) (24)
Studies on enteropathogenic activity of Vibrio parahaemolyticus using ligated gut loop model in rabbits. (1974) (24)
Electron Microscopic Study of a Herpes‐Type Virus Isolated from an Infant with Exanthem Subitum (1989) (24)
Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. (1995) (24)
Viruses of hemorrhagic fever with renal syndrome (HFRS) grouped by immunoprecipitation and hemagglutination inhibition. (1987) (24)
Experimental herpes simplex virus and cytomegalovirus labyrinthitis. (1989) (23)
Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization. (1997) (23)
Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus). (2011) (23)
Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand (1996) (22)
Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection. (2001) (22)
Human immune responses elicited by an intranasal inactivated H5 influenza vaccine (2020) (22)
Amplification and detection of a single molecule of human immunodeficiency virus RNA (1993) (21)
Tristetraprolin inhibits HIV-1 production by binding to genomic RNA. (2006) (21)
31 – Intranasal Immunization with Influenza Vaccine (1996) (21)
Increased Levels of ɛ and γ Isoforms of 14-3-3 Proteins in Cerebrospinal Fluid in Patients with Creutzfeldt-Jakob Disease (1999) (21)
ACUTE PANCREATITIS WITH CYTOMEGALOVIRUS INFECTION (1987) (21)
Analysis of Linear B-Cell Epitopes of the Nucleoprotein of Ebola Virus That Distinguish Ebola Virus Subtypes (2003) (21)
The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice (2005) (21)
The Interaction of Mitogen-Activated Protein Kinases to Epstein-Barr Virus Activation in Akata Cells (2004) (21)
An animal model of type-1 herpes simplex virus infection of facial nerve. (1988) (21)
Distribution of human herpesvirus 6 and varicella‐zoster virus in organs of a fatal case with exanthem subitum and varicella (1996) (20)
Genetic analysis of HIV type 2 from Ghana and Guinea-Bissau, West Africa. (2001) (20)
Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue (2004) (20)
Genetic and phylogenetic analysis of HIV type 1 strains from southern Ghana. (1998) (19)
Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase. (2002) (19)
Disseminated Adenovirus (Type 19) Infection in a Neonate Rapid Detection of the Infection by Immunofluorescence (1990) (19)
Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit. (1990) (19)
Cellular and humoral immune responses in mice. I. Development of delayed-type footpad swelling against sheep erythrocytes and its suppression by intraperitoneal administration of the antigen. (1973) (19)
Fetal death associated with measles virus infection of the placenta. (1991) (19)
Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone. (2004) (19)
MODIFICATIONS TO INDIRECT IMMUNOFLUORESCENCE TESTS ON LASSA, MARBURG, AND EBOLA MATERIAL (1983) (18)
Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus (2007) (18)
Specific reduction in Na currents after infection with herpes simplex virus in cultured mammalian nerve cells (1983) (18)
Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus. (2009) (18)
Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration. (1995) (18)
Continuity and change of Japanese encephalitis virus in Toyama Prefecture, Japan. (2011) (18)
Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. (2000) (18)
Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. (2003) (18)
Distribution of gentamicin by immunofluorescence in the guinea pig inner ear (2004) (18)
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. (2007) (18)
Replication of human herpesvirus 6 (HHV-6): morphological aspects. (1990) (17)
Human herpesvirus 6 infection of human epidermal cell line: Pathogenesis of skin manifestations (2003) (17)
Peanut Agglutinin Receptor Is a Marker of Myelin in Rat Brain. Developmental Changes in Its Distribution (1986) (17)
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine (2012) (17)
Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP‐capture enzyme‐linked immunosorbent assay (2005) (17)
Viral pathology of human herpesvirus 6 infection. (1990) (17)
The seroprevalence of human herpesvirus 8 infection in the Thai population. (2002) (17)
Mechanisms of hearing disturbance in an autoimmune model mouse NZB/kl. (1994) (17)
Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse. (2000) (17)
Demonstration of vaccinia virus antigen in brains of postvaccinal encephalitis cases. (1977) (17)
Detection of a novel recombinant norovirus from sewage water in toyama prefecture, Japan. (2009) (16)
Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection. (1997) (16)
Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. (1994) (16)
Middle Ear Mucosa in Ramsay Hunt Syndrome (1990) (16)
Detection of hepatitis C virus genome in paraffin-embedded tissues by nested reverse transcription polymerase chain reaction (1994) (16)
Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines. (1998) (15)
Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model (1999) (15)
Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens. (2001) (15)
Morphological and physiological studies on cultured nerve cells from guinea pigs infected with herpes simplex virus in vivo (1983) (15)
Human topoisomerase I promotes HIV-1 proviral DNA synthesis: Implications for the species specificity and cellular tropism of HIV-1 infection (2003) (15)
Evaluation of Antibodies to the Epstein-Barr Virus Immediate Early Gene Product ZEBRA by a New Enzyme-Linked Immunosorbent Assay (1999) (14)
Differential Effect of TPA on Cell Growth and Epstein-Barr Virus Reactivation in Epithelial Cell Lines Derived from Gastric Tissues and B Cell Line Raji (2004) (14)
Single Base Substitutions in the Capsid Region of the Norovirus Genome during Viral Shedding in Cases of Infection in Areas Where Norovirus Infection Is Endemic (2008) (14)
Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys. (2001) (14)
Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. (2001) (14)
Varicella‐zoster virus replication site in internal organs of an otherwise healthy child with varicella and sudden death (1993) (14)
The Rash of Measles Is Caused by a Viral Infection in the Cells of the Skin: A Case Report (1994) (14)
Distribution of herpes simplex virus types 1 and 2 genomes in human spinal ganglia studied by PCR and in situ hybridization (1997) (14)
Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation. (2000) (13)
Dicer and positive charge of proteins decrease the stability of RNA containing the AU-rich element of GM-CSF. (2006) (13)
ACTIVATION OF CYTOMEGALOVIRUS INFECTION IN IMMUNOSUPPRESSED CYNOMOLOGUS MONKEYS INOCULATED WITH VARICELLA‐ZOSTER VIRUS (1986) (13)
Infection of a human retinal pigment epithelial cell line with human herpesvirus 6 variant A (1997) (13)
The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon. (1998) (13)
Evolution of cell-surface acid phosphatase of Burkholderia pseudomallei. (1996) (13)
A preliminary survey for human immunodeficient virus (HIV) infections in tuberculosis and melioidosis patients in Ubon Ratchathani, Thailand. (1992) (13)
Human herpesvirus 6 latently infects mononuclear cells but not liver tissue. (1999) (13)
BCL-6-positive Human Herpesvirus 8-associated Solid Lymphoma Arising from Liver and Spleen as Multiple Nodular Lesions (2004) (13)
Analysis of human lymphotropic T-cell virus type II-like particle production by recombinant baculovirus-infected insect cells. (1999) (13)
Demonstration of acid phosphatase activity in antigenic glycoprotein fractions obtained from the culture filtrate of Pseudomonas pseudomallei. (1991) (12)
Binding of human cytomegalovirus to sulfated glucuronyl glycosphingolipids and their inhibitory effects on the infection. (1998) (12)
Analysis of viral antigens in giant cells of measles pneumonia by immunoperoxidase method (1987) (12)
Enteropathogenicity and enterotoxigenicity of human enteropathogenic Escherichia coli. (1974) (12)
A novel neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody. (1996) (12)
Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins. (2000) (11)
Topoisomerase I and ATP activate cDNA synthesis of human immunodeficiency virus type 1. (2002) (11)
[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers]. (1997) (11)
Novel Real-Time Monitoring System for Human Cytomegalovirus- Infected Cells In Vitro That Uses a Green Fluorescent Protein-PML-Expressing Cell Line (2006) (11)
The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry. (1999) (11)
Application of the hybridization AT-tailing method for detection of human immunodeficiency virus RNA in cells and simian immunodeficiency virus RNA in formalin-fixed and paraffin-embedded tissues. (1999) (10)
CYTOMEGALOVIRUS OOPHORITIS WITH CORTICAL NECROSIS DURING REMISSION OF ACUTE LYMPHOCYTIC LEUKEMIA (1988) (10)
Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines (2011) (10)
Unexpected correlation in the sensitivity of 19 herpes simplex virus strains to types I and II interferons. (1997) (10)
Highly variable sequences in the env V3 region of HIV type 1 distributing among Thai carriers from 1995 to 1997. (2000) (10)
Effects of hydrocortisone on the in vitro primary immune response of mouse spleen cells to sheep erythrocytes. (1972) (10)
Specific binding of Burkholderia pseudomallei cells and their cell-surface acid phosphatase to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). (1997) (9)
Producer cell-dependent requirement of the Nef protein for efficient entry of HIV-1 into cells. (1998) (9)
Affinity and response of Burkholderia pseudomallei and Burkholderia cepacia to insulin. (1996) (9)
Experimental labyrinthitis in guinea pigs caused by a hantavirus. (1991) (9)
Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease. (1999) (9)
Full-length sequences of two CRF01_ae (subtype e) HIV type 1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand. (2001) (9)
Myocardial lesions by Coxsackie virus B3 and cytomegalovirus infection in infants (2005) (9)
An immunodominant neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by phage display antibodies. (2001) (8)
Simian betaretrovirus infection in a colony of cynomolgus monkeys (Macaca fascicularis). (2010) (8)
Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan (2008) (8)
The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin's disease (2005) (8)
Genome variation among varicella-zoster virus isolates derived from different individuals and from the same individuals (2005) (8)
Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant. (1997) (8)
Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies (2005) (7)
Widespread Circulation of Echovirus Type 13 Demonstrated by Increased Seroprevalence in Toyama, Japan, between 2000 and 2003 (2010) (7)
Lethal disease in infant and juvenile Syrian hamsters experimentally infected with Imjin virus, a newfound crocidurine shrew-borne hantavirus. (2015) (7)
Suppression of Specific IgE Antibody Responses by Liposome-Conjugated Ovalbumin in Mice Sensitized with Ovalbumin via the Respiratory Tract (2000) (7)
An immunofluorescent study of generalized infection of human cytomegalovirus in a patient with systemic lupus erythematosus (1984) (7)
Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction. (2009) (7)
WIDESPREAD ECZEMA VACCINATUM ACQUIRED BY CONTACTS A Report of an Autopsy Case (1979) (7)
Establishment and Characterization of a Woodchuck Hepatocellular Carcinoma Cell Line (WH44KA) (1988) (7)
Non-A, non-B hepatitis: visualization of virus-like particles from chimpanzee and human sera (2005) (7)
Topoisomerase I dissociates human immunodeficiency virus type 1 reverse transcriptase from genomic RNAs. (2004) (7)
Binding and dissociation of human topoisomerase I with hairpin-loop RNAs: implications for the regulation of HIV-1 replication. (2002) (7)
Reconstitution of cleavage of human immunodeficiency virus type-1 (HIV-1) RNAs. (2002) (7)
Production of monoclonal antibodies by the use of pH-dependent vesicular stomatitis virus-mediated cell fusion. (1991) (7)
Detection of adeno-associated virus type 2 in patients with viral infection. (1999) (6)
Consistent appearance of microtubules in cells productively infected with various strains of type 2 herpes simplex virus. (1981) (6)
Spontaneous reduction in Epstein-Barr virus (EBV) DNA copy number in EBV-infected epithelial cell lines. (2001) (6)
Endemic transmission of echovirus 30 in Toyama, Japan in 2010 is verified by environmental surveillance. (2011) (6)
Effects of Cholera Toxin on Delayed‐Type Hypersensitivity to Sheep Red Blood Cells Inoculated Intranasally into Mice (1988) (6)
Localization of herpes simplex virus type 1 in sebaceous glands of mice (2005) (6)
Processing of the HTLV-II envelope precursor glycoprotein gp63 by furin is essential for cell fusion activity. (2002) (5)
Experimental labyrinthitis in rats caused by infecting with virus causing hemorrhagic fever with renal syndrome (HFRS). (1989) (5)
In vitro and in vivo analysis of human herpesvirus‐6 U90 protein expression (2005) (5)
Rosette-forming cells and plague-forming cells in primary immune response in vitro. (1972) (5)
Characterization of EBV-infected epithelial cell lines from gastric cancer-bearing tissues. (2001) (5)
Estimating tissue permeability and other bioelectrical parameters using membrane voltage and short-circuit current. (1991) (5)
Herpes Virus Infections in Human Pancreas Islets and Animal Models (1987) (5)
Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2‐repeat regions (2002) (5)
Herpes encephalitis and paraneoplastic limbic encephalitis (1998) (5)
Enhancement of DTH Response by Cholera Toxin B Subunit Inoculated Intranasally Together with Influenza HA Vaccine (1990) (5)
Experiments on herpes simplex viral infections of the facial nerve in the tympanic cavity (2004) (5)
Case report of adult T-cell leukemia with preceding long-standing cutaneous involvement. (1983) (5)
A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases (2004) (5)
EXPERIMENTAL ACTIVATION OF LATENT CYTOMEGALOVIRUS INFECTION OF THE CAPTIVE BRED (F1) CYNOMOLGUS MONKEYS BY LIVE OR KILLED VARICELLA‐ZOSTER VIRUS INOCULATED UNDER IMMUNOSUPPRESSION (1988) (5)
Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance. (2014) (4)
Transgenic Mice Carrying the Human Poliovirus Receptor : New Animal Model for Study of Poliovirus Neurovirulence HITOSHI HORIE , " 2 (2003) (4)
Molecular genetic approaches to the pathogenesis of bacillary dysentery. (1988) (4)
Endotoxin content in Haemophilus influenzae type b vaccine. (2004) (4)
Prevalences of human herpesvirus 6 and human herpesvirus 7 in normal Thai population. (1999) (4)
Serosurveillance for double infection with Pseudomonas pseudomallei in tuberculous patients. (1992) (4)
[Detection and identification of mycobacterial DNA with sputa and AIDS samples by nested-polymerase chain reaction (nested-PCR)]. (1993) (4)
Human herpesvirus‐6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients (1995) (4)
Survey of tick fauna possessing the ability to act as vectors of rickettsiosis in Toyama Prefecture, Japan. (2009) (4)
Four autopsy cases of acute viral myocarditis (1985) (3)
VESICULAR STOMATITIS VIRUS-MEDIATED CELL FUSION SUBSEQUENT TO VIRUS ADSORPTION AT DIFFRENT pH VALUES (1991) (3)
Evaluation of a Rapid Test for Determination of Most Probable Number of Viable Vibrio parahaemolyticus by Using Etidium Monoazide (2011) (3)
Detection of varicella-zoster virus DNA in cultured cells and tissue specimens by in situ hybridization using biotin-labeled probes. (1987) (3)
[Diagnosis of varicella-zoster virus (VZV) infection by using FITC-labeled monoclonal antibodies]. (1990) (3)
Enhanced cytopathic effect of human cytomegalovirus on a retinal pigment epithelium cell line, K-1034, by serum-free medium (1997) (3)
[Typing of herpes simplex virus in patients with uveitis]. (2000) (3)
[Therapeutic effect of ara-A on herpes simplex virus encephalitis]. (1982) (3)
[Studies on the serological diagnosis of herpes simplex virus encephalitis (HSVE)--the significance of ELISA]. (1984) (3)
Virological studies of smallpox in an endemic area. I. Evaluation of immunofluorescence staining as a rapid diagnostic procedure in the field. (1977) (3)
[Histopathological findings in cytomegalovirus retinitis]. (2004) (3)
Application of indirect immunofluorescence microscopy to colony identification of Pseudomonas pseudomallei. (1993) (3)
Measles associated with coronary arteritis (2005) (3)
Review: collected materials and records of HIV/AIDS prevalence and the contemporary social changes in Thailand. (1995) (3)
Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers. (1997) (3)
Varicella Zoster Virus Antigens in the Epidermis of Patients with Herpes Zoster before and after Treatment with Acyclovir: An Immunohistochemical Study (2001) (2)
[Experimental inner ear pathology with herpes simplex virus infection II. Intralabyrinthine inoculation of herpes simplex virus in guinea pigs]. (1982) (2)
Construction of Extended π-Conjugation Systems Utilizing Novel Multicarbene Complexes of Titanium (2007) (2)
Virological studies of smallpox in an endemic area. II. Virus content of clinical specimens and typing of virus isolates. (1977) (2)
A fatal case of type 2 herpes simplex virus infection in a newborn. (1973) (2)
Systemic Deposition of Viral Antigens in the Vascular Endothelia of Hemorrhagic Fever with Renal Syndrome (1987) (2)
Vertical transmission of type I and type 2 Herpes simplex virus infection in hamsters. (1976) (2)
Herpes simplex encephalitis: an autopsy case with isolation of type 1 herpes simplex virus (1977) (2)
Monoclonal antibodies against topoisomerase I suppressed DNA relaxation and HIV-1 cDNA synthesis. (2000) (2)
Vertical transmission of type 2 herpes simplex virus infection in immunosuppressed hamsters. (1978) (2)
[Diagnosis of varicella-zoster virus infection by immunological method]. (1989) (2)
[Experimental inner ear pathology with herpes simplex virus infection. I. Intracerebral inoculation of herpes simplex virus in mice]. (1982) (2)
Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination. (2002) (2)
[Mucosal immune responses against influenza virus]. (1997) (2)
[Crimean-Congo hemorrhagic fever]. (1999) (1)
Effect of Transforming Growth Factor-b 1 on the Cell Growth and Epstein – Barr Virus Reactivation in EBV-Infected Epithelial Cell Lines (2001) (1)
Vesicular stomatitis virus-mediated cell fusion subsequent to virus adsorption at different pH values. (1991) (1)
Post-Exposure Vaccination with a Highly Attenuated Vaccinia Vaccine, LC16m8, for Protection of Nonhuman Primates from Monkeypox (2008) (1)
[The detection of varicella-zoster virus (VZV) antigen from vitreous humor of 3 cases with Kirisawa-Urayama type uveitis]. (1988) (1)
[Detection of herpes simplex virus (HSV) infection by using FITC-labeled monoclonal antibodies (MicroTrak method)]. (1987) (1)
[Viral hemorrhagic fevers]. (1993) (1)
Prognosis and progression of non-A, non-B hepatitis: Long-term follow up study in chimpanzees. (1988) (1)
Short Communication Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates (2009) (1)
Role of nucleotide sequences in the V3 region in efficient replication of CCR5-utilizing human immunodeficiency virus type 1 in macrophages. (2002) (1)
Survey for Pneumocystis carinii infection of wild-born and laboratory-bred monkeys by indirect immunofluorescence and cyst-staining methods. (1996) (1)
Immunohistochemical studies on the mechanism of hepatocellular injury of acute CMV hepatitis in previously healthy adults. (1989) (1)
AIDS dementia and HIV‐1 replication (1997) (1)
[Emerging infectious diseases--Ebola hemorrhagic fever]. (1997) (1)
Detection of Herpes Simplex and Varicella‐Zoster Virus DNA by Field‐Inversion Gel Electrophoresis from Clinical Materials (1992) (1)
Cervical intra‐epithelial neoplasia (CIN) III of the uterine cervix in a young female associated with AIDS (1996) (1)
Demonstration of herpes simplex 1 virus antigen mouse brain after fixation. (1986) (1)
Recombinant nucleoprotein-based diagnostic systems for Lassa fever: development of diagnostic assays, which do not require infectious virus for antibody and antigen detection Short title: Recombinant NP-based diagnostics for Lassa fever (2007) (0)
[Effect of ara-A on the experimental herpes simplex virus encephalitis--pathology and fluctuation of the cerebrospinal fluid and serum antibody levels]. (1983) (0)
Survey of Preference on Eating Raw Meats as an Etiology of Enterohemorrhagic Escherichia coli Infectious Disease (2010) (0)
Transfer of delayed hypersensitivity induced by Schistosoma japonicum adult worm antigen in guinea pigs. (1983) (0)
Western analysis and subcellular localization of the hA3 family proteins (2011) (0)
The histological changes of cutaneous nerves around the involved hair follicles in herpes zoster (1992) (0)
[Viral hemorrhagic fever]. (2003) (0)
Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious disease. Infectious diseases such as Ebola, etc. ( haemorrhagic fever ). (1997) (0)
Low-neurovirulence and effective immunogenicity of recombinant vaccinia virus constructed from LCl6mO or LCl6m8 strain (1988) (0)
Distribution of Gentamicin in Guinea Pig's Inner Ear by Indirect Immunofluorescence technique (1984) (0)
Experimental Inner Ear Pathology with Herpes Simplex Virus Infection in Guinea Pigs (1982) (0)
Analysis of HTLV-II syncytium formation using recombinant cowpoxvirus expressing the evelope precursor glycoprotein,gp63. (1999) (0)
[Progress of diagnostic methods for antigens and antibody testing of type 1 and 2 herpes simplex viruses]. (1989) (0)
[Cold agglutinin disease (CAD), paroxysmal cold hemoglobinuria (PCH) and intravascular hemolysis]. (1979) (0)
Studies on Genetic Testing Using Internal Control to Avoid False-negative Results in the Official Method for Isolation of Escherichia coli O157 and O26 from Food (2009) (0)
[Primary macroglobulinemia with neoplasm formation]. (1975) (0)
Adjuvant-Combined Vaccines Immunized Intranasally with in Polymeric Ig Receptor Knockout Mice Protection Against Influenza Virus Infection (2002) (0)
Characterization of bone-associated tumor in chronic myelogenous leukemia: a case report. (1982) (0)
Cochlear and Renal Pathology in Murine Lupus. (1991) (0)
[2 autopsy cases of fulminant herpes simplex encephalitis]. (1983) (0)
Immune Responses to Epstein-Barr Viral Infection (2002) (0)
Correspondence for infectious diseases under infectious diseases '99 "infectious disease new law" . III. Typology of infectious disease Concept of disease and correspondence. 1.1 Class 1 infectious disease. 1 Virus. (1999) (0)
Experimental transmission of woodchuck hepatitis virus to woodchucks. (1989) (0)
Inhibition of the mutagenicity of MX and MeIQx by Wasabi (Wasabia japonica) (1995) (0)
Herpes simplex virus infection of the facial nerve in guinea pigs (1985) (0)
Pathogenicity of a vaccine strain of vaccina virus in rabbits administered by intravenous route. (1977) (0)
Joint Symposium The 2nd International Symposium: Polyomaviruses and Human Diseases and 4th International Symposium for Zoonosis Control “Emerging Virus Infections” (2011) (0)
Vol. 41, 1998 (1999) (0)
Construction of Extended π‐Conjugation Systems Utilizing Novel Multicarbene Complexes of Titanium. (2007) (0)
Endogenous expressions of hA3 family members in primary and established cells (2011) (0)
[Autopsy case of Goodpasture's syndrome associated with peculiar interstitial pneumonitis and nephritis]. (1971) (0)
mouse ) in nasal wash in nasal wash 0 IO 20 30 40 50 0 1 2 3 4 5 L JgA 口 19 (2010) (0)
In memory of Dr. Akira Oya (2008) (0)
[Autopsy case of herpes encephalitis in an infant]. (1971) (0)
Typing of Herpes Simplex Virus in Patients with Uveitis. (2001) (0)
[Class 1 infections: 1) Viral diseases]. (1999) (0)
[Hantavirus infection]. (1999) (0)
Detection of Viral Antigens after Fixation and Decalcification (1981) (0)
Covalent bonded Gag multimers in human immunodeficiency virus type‐1 particles (2009) (0)
Epidemic occurrence of an acute, erythematous eruptionmimicking contact dermatitis: a new disease? (2000) (0)
[A case of small cell variant Sézary syndrome (author's transl)]. (1978) (0)
[Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases]. (1986) (0)
Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein. (1994) (0)
[Viral hemorrhagic fevers as international infectious diseases--epidemiology, virology and clinical symptoms]. (1989) (0)
Animal Model of Herpes Simplex Virus Infection of the Facial Nerve in Guinea Pigs (1986) (0)
[A case of T cell CLL complicated with Mikulicz syndrome (author's transl)]. (1980) (0)
Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry. (2004) (0)
[Pathology of human cytomegalovirus infection in immunocompromised hosts]. (1998) (0)
Analysis of HTLV-II-like particle production by recombinant baculovirus-infected insect cells. (1999) (0)
SIMPOSIUM IV “CROSS-FIRE : TROPICAL MEDICINE VS. INTERNATIONAL HEALTH” (2000) (0)
Treatment of alcoholic pancreatitis (Case report) (1969) (0)
Emerging & Re-Emerging Infectious Diseases : How to Fight against Them? (2009) (0)
Enhanced intrauterine transmission of herpes simplex virus infection in immunosuppressed hamsters. (1981) (0)
A CASE OF CYTOMEGALOVIRUS ESOPHAGITIS (1988) (0)
Immunohistological observation of the Cochlea Using the Serum from the Patient with Relapsing Polychondritis (1988) (0)
Optical microscopic observation on acute CMV hepatitis in healthy adults and detection of CMV antigen by ABC method. (1990) (0)
[Detection of human papillomavirus DNA using in situ hybridization]. (1992) (0)
Viral hemorrhagic fever : epidemiology and control (1998) (0)
[Pathology of herpesvirus infections]. (1986) (0)
Subject Index Vol. 41, 1998 (1999) (0)
[Sexually transmitted disease infection in HIV carriers]. (1994) (0)
[Pathology and pathogenesis of varicella and zoster (author's transl)]. (1976) (0)
Antibodies to hepatitis C virus in serum of chimpanzees infected with non-A, non-B hepatitis: Problem of silent infection. (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With T. Takeyuki Kurata?

T. Takeyuki Kurata is affiliated with the following schools:

T. Takeyuki Kurata's Academic­Influence.com Rankings

T. Takeyuki Kurata's Degrees

Why Is T. Takeyuki Kurata Influential?

T. Takeyuki Kurata's Published Works

Published Works

What Schools Are Affiliated With T. Takeyuki Kurata?

T. Takeyuki Kurata's AcademicInfluence.com Rankings